Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Lenalidomide, Vorinostat, and Dexamethasone in Relapsed/Refractory PTCL
NCT00972842Phase 2Terminated
- Sponsor
- Arbeitsgemeinschaft medikamentoese Tumortherapie
- Start
- Sep 2009
- Primary completion
- Jul 2012
- Modality
- Covalent Small Molecules, Classical Binding Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of lenalidomide, vorinostat in peripheral T-cell lymphoma (PTCL), sponsored by Arbeitsgemeinschaft medikamentoese Tumortherapie. Started Sep 2009; status: terminated.
02
Drugs
lenalidomidevorinostat
03
Conditions
peripheral T-cell lymphoma (PTCL)
Beyond the preview
Go deeper on NCT00972842.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00972842.